Loading...

Canopy Growth Corporation

CGC•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$1.44
$0.17(13.39%)

Canopy Growth Corporation (CGC) Stock Overview

Explore Canopy Growth Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

C+

Score: 58.5/100

Key Financials

Market Cap345.3M
P/E Ratio-0.74
EPS (TTM)$-3.03
ROE-0.99%
Fundamental Analysis

AI Price Forecasts

1 Week$1.55
1 Month$0.54
3 Months$0.49
1 Year Target$0.74

CGC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Canopy Growth Corporation (CGC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 58.15, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.74.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.74 and a market capitalization of 345.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-4.35%
5-Day Change
-8.14%
1-Month Change
-21.91%
3-Month Change
-64.94%
6-Month Change
-78.42%
Year-to-Date (YTD) Change
-70.17%
1-Year Change
-90.58%
3-Year Change
-98.75%
5-Year Change
-99.41%
All-Time (Max) Change
-76.34%

Contact Information

https://www.canopygrowth.com
855 558 9333
1 Hershey Drive, Smiths Falls, ON, K7A 0A8

Company Facts

1,029 Employees
IPO DateApr 7, 2014
CountryCA
Actively Trading

Frequently Asked Questions

;